Latest Breaking News On - Cellera biologics - Page 5 : comparemela.com

Equities Research Analysts' Upgrades for February 22nd (ABCL, AMEH, AMWD, BELFB, BEP, COTY, DASH, FM, GGAL, GTES)

Equities Research Analysts' Upgrades for February 22nd (ABCL, AMEH, AMWD, BELFB, BEP, COTY, DASH, FM, GGAL, GTES)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdGrupo financiero galiciaFirst quantum mineralsHealthcare services groupRibbon communicationsKite realty group trustCentrus energyLiberty siriusxm groupMorgan stanleyAmerica coAbcellera biologics incEquities research analystNews ratings for abcellera biologics inc dailyCantor fitzgeraldJefferies financial group inc

Skandinaviska Enskilda Banken AB publ Acquires 3,000 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)

Skandinaviska Enskilda Banken AB publ raised its holdings in AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 3.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 83,867 shares of the company’s stock after acquiring an additional 3,000 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in AbCellera Biologics were worth $386,000 at […]

Skandinaviska enskilda bankenAbcellera biologicsEli lillyJanney montgomery scottCookson peirce coSecurities incPathstone family officeHightower advisorsAbcellera biologics incFree reportEnskilda bankenTower advisorsFamily officeMontgomery scottBloom burtonCellera biologics

AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price […]

Eli lillyAbcellera biologicsAbcellera biologics incArrowmark colorado holdingsRenaissance technologiesLazard asset managementGet free reportCellera biologicsMark colorado holdingsStreet corpAsset managementProsight managementGet freeCellera biologics incConfo therapeuticsAbcellera biologics daily

AbCellera Biologics: Continuing To Expand Partnerships (NASDAQ:ABCL)

AbCellera Biologics: Continuing To Expand Partnerships (NASDAQ:ABCL)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

British columbiaAbcellera biologicsRabindranath tagorePiper sandlerAbcellera biologics incCompany overviewDevelopmental partners november company presentationDevelopmental benefits november company presentationDevelopmental approach november company presentationCompany presentationCanadian government funding november company presentationCellera biologicsNovember companyGovernment fundingQuarter resultsEli lilly

AbCellera Biologics (NASDAQ:ABCL) Shares Down 4.8%

AbCellera Biologics (NASDAQ:ABCL) Shares Down 4.8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Recursos ltdaAbcellera biologicsPiper sandlerEli lillyAbcellera biologics incCedar brook financial partnersChina universal asset management coRaymond james financial services advisors incPiper sandler companiesGet free reportSandler companiesCellera biologicsUniversal asset managementGestao de recursosJames financial services advisorsBrook financial partners